Theravance Biopharma Inc Cash Flow Quality Index
Theravance Biopharma Inc cash flow quality index. Theravance Biopharma Inc (TBPH) has a Cash Flow Quality Index of -0.10x as of December 2025. Operating cash flow of $-6.06 Million is below net income of $61.02 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Theravance Biopharma Inc (TBPH) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Theravance Biopharma Inc (2025–2025)
Cash flow quality index of Theravance Biopharma Inc from 2025 to 2025. Historical Cash Flow Quality Index for Theravance Biopharma Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Theravance Biopharma Inc (TBPH) balance sheet quality index to measure how much of total assets are equity-financed.
Theravance Biopharma Inc Cash Flow Quality Index by Year (2025–2025)
Theravance Biopharma Inc cash flow quality index by year from 2025 to 2025. Year-by-year earnings quality comparison for Theravance Biopharma Inc. For the full cash flow conversion analysis, see how efficiently does Theravance Biopharma Inc generate cash.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.25x | $238.54 Million | $105.89 Million | — |